2-Cyclohexen-1-one, 3-chloro-5,5-dimethyl-, 98%, 25g

ATRACTYLENOLIDE III, 98%, 25mg

5-[3-(furan-2-amido)benzamido]-2-hydroxybenzoic acid, 95.0%, 10mg

Récipient à échantillons Type 2118, 30 ml, 12 pièce(s)

1-[(3aS,8aS)-tetrahydro-2,2-diMethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]- Piperidine, 98%, 250mg

2-(3-fluoropyridin-2-yl)ethan-1-ol, 95.0%, 250mg

(R)-3-Amino-4-(2,4-dichlorophenyl)butanoic acid hydrochloride, 95.0%, 5g

5H-pyrrolo[3,2-d]pyrimidine-4-carboxylic acid, 250mg

(S)-3-(3-Aminophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 1g

5-Chloro-3-fluoro-2-iodoaniline, 98%, 100mg

5-Chloro-2,4-diaminoquinazoline, 95.0%, 1g

Methyl 4-amino-3-(trifluoromethyl)benzoate, 95.0%, 250mg

2-(2-Fluorobenzyl)acetoacetic acid ethyl ester, 95.0%, 1g